ATLANTA--(BUSINESS WIRE)--Dec. 22, 2004--ProxyMed, Inc. (Nasdaq:PILL) (the “Company”), a leading provider of healthcare transaction processing and medical cost containment services, announced today that in keeping with good corporate governance practices it will separate the roles of the Company’s Chairman and Chief Executive Officer. Kevin McNamara, who previously served as the Chairman of the Audit Committee of the Board, will serve as the new Chairman of the Board. Michael Hoover will continue to serve as the Chief Executive Officer of the Company. In addition to serving as the Chairman of the Board, Mr. McNamara has entered into a consulting arrangement with Company reflecting his increased level of activity at the Company.
